188 related articles for article (PubMed ID: 9043561)
1. Cost savings and avoidance from clinical interventions.
Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
[TBL] [Abstract][Full Text] [Related]
2. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
[TBL] [Abstract][Full Text] [Related]
3. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
4. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
5. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
6. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
7. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
8. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand.
Sukkha S; Rattanavipanon W; Chamroenwit B; Sanganurak M; Nathisuwan S; Chaikledkaew U; Kongwatcharapong J
Int J Clin Pharm; 2020 Apr; 42(2):610-616. PubMed ID: 32221826
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
10. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital.
Janning SW; Stevenson JG; Smolarek RT
Am J Health Syst Pharm; 1996 Mar; 53(5):542-7. PubMed ID: 8697014
[TBL] [Abstract][Full Text] [Related]
11. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
12. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
Zaidi ST; Hassan Y; Postma MJ; Ng SH
Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
[TBL] [Abstract][Full Text] [Related]
14. An analysis of pharmacist interventions.
Torchinsky A; Landry D
Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
[TBL] [Abstract][Full Text] [Related]
15. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team.
Patel NP; Brandt CP; Yowler CJ
J Burn Care Res; 2006; 27(3):310-3. PubMed ID: 16679898
[TBL] [Abstract][Full Text] [Related]
17. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
18. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.
Dooley MJ; Allen KM; Doecke CJ; Galbraith KJ; Taylor GR; Bright J; Carey DL
Br J Clin Pharmacol; 2004 Apr; 57(4):513-21. PubMed ID: 15025751
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
20. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
